Cloud Banner

Healthcare

Image

Asia-Pacific Infusion Pumps Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Oct 2023
  • Asia-Pacific
  • 150 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia-Pacific Infusion Pumps Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 4.9% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 4.40 Billion
Diagram Market Size (Forecast Year) USD 6.67 Billion
Diagram CAGR 4.9%

Asia-Pacific Infusion Pumps Market, By Type (Traditional Infusion Pumps, Specialty Infusion Pumps), Accessories and Consumables (Volumetric Infusion Pumps, Insulin Pumps, Enteral Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, PCA Pumps, Implantable Infusion Pumps, Infusion Catheters, IV/Administration Sets, Needleless Connectors, Cannulas, Tubing and Extension Sets, Valves, Others), Application (Hemotherapy/Oncology, Diabetes, Gastroenterology, Analgesia/Pain Management, Paediatrics/Neonatology, Haematology, Other), End User (Hospitals, Home Care Settings, Ambulatory Care Settings, Academic and Research Institutes) – Industry Trends and Forecast to 2030.

Asia-Pacific Infusion Pumps Market Analysis and Size

The Asia-Pacific infusion pumps market is a dynamic and rapidly evolving sector within the healthcare industry. Infusion pumps are crucial medical devices used to administer fluids, medications, and nutrients to patients in a controlled and precise manner. This market in the Asia-Pacific region is driven by several factors, including the increasing prevalence of chronic diseases, a growing aging population, and a rising demand for advanced healthcare solutions. The need for efficient and accurate drug delivery systems is propelling the adoption of infusion pumps in hospitals, clinics, and home healthcare settings across the region. Technological advancements, such as the integration of smart features and wireless connectivity, are enhancing the overall functionality and usability of infusion pumps. Moreover, healthcare providers are focusing on reducing healthcare costs and improving patient outcomes, which further boosts the demand for innovative infusion pump solutions.

Data Bridge Market Research analyses that the Asia-Pacific infusion pumps market which was USD 4.40 billion in 2022, is expected to reach USD 6.67 billion by 2030, and is expected to undergo a CAGR of 4.9% during the forecast period 2023-2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Asia-Pacific Infusion Pumps Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Traditional Infusion Pumps, Specialty Infusion Pumps), Accessories and Consumables (Volumetric Infusion Pumps, Insulin Pumps, Enteral Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, PCA Pumps, Implantable Infusion Pumps, Infusion Catheters, IV/Administration Sets, Needleless Connectors, Cannulas, Tubing and Extension Sets, Valves, Others), Application (Hemotherapy/Oncology, Diabetes, Gastroenterology, Analgesia/Pain Management, Paediatrics/Neonatology, Haematology, Other), End User (Hospitals, Home Care Settings, Ambulatory Care Settings, Academic and Research Institutes)

Countries Covered

Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific

Market Players Covered

BD (Becton, Dickinson and Company) (U.S.), B. Braun Melsungen AG (Germany), Baxter (U.S.), Fresenius Kabi AG (Germany), ICU Medical, Inc. (U.S.), Smiths Group PLC (U.K.), Medtronic (U.S.), Moog Inc. (U.S.), Terumo Corporation (Japan), Avanos Corporate (U.S.), NIPRO (Japan), Insulet Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), JMS Co. Ltd. (Japan), F. Hoffmann-La Roche Ltd. (Switzerland)

Market Opportunities

  • Rising number of surgical procedures.
  • The growing geriatric population.
  • The rising incidence of chronic diseases.

Market Definition

Infusion pumps are medical devices used to deliver fluids, such as medications, nutrients, or other therapeutic substances, into a patient's body in a controlled and precise manner. These devices are crucial in healthcare settings, including hospitals, clinics, and home healthcare, to administer fluids intravenously (IV), subcutaneously, or epidurally. The infusion pump accurately controls the rate and volume of the fluid being delivered, ensuring that patients receive the prescribed dose at the correct speed and duration. This precision is vital for medications that require specific infusion rates or for patients with critical medical conditions.

Asia-Pacific Infusion Pumps Market

Drivers

  • Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and neurological disorders in the Asia-Pacific region is a major driver for the infusion pumps market. Infusion pumps play a vital role in the continuous and precise administration of medications for managing chronic conditions, thereby propelling the demand for these devices.

  • Technological Advancement and Innovation

Ongoing advancements in infusion pump technology, including the development of smart infusion systems, integration of wireless connectivity, enhanced safety features, and the ability to administer multiple therapies simultaneously, are driving market growth. These technological innovations are improving the accuracy, efficiency, and safety of infusion pumps, encouraging their adoption in healthcare settings across the Asia-Pacific region.

Opportunity

  • Rapidly Growing Home Healthcare Market

The expanding home healthcare sector in the Asia-Pacific region presents a significant opportunity for the infusion pumps market. Increasing preference for home-based care due to its convenience, cost-effectiveness, and the growing elderly population requiring long-term care encourages the use of infusion pumps in a home setting. Infusion pumps enable controlled and monitored drug administration outside of healthcare facilities, aligning with the trend of shifting healthcare from hospitals to homes.

Restraint/Challenge

  • High Cost of Infusion Pumps System

The high initial cost of infusion pump systems, including the device itself, accessories, and maintenance, can act as a restraint for market growth in the Asia-Pacific region. The affordability and cost-effectiveness of these devices pose challenges for adoption, particularly in emerging economies where healthcare budgets may be constrained. Cost-sensitive markets may require targeted strategies to address price concerns and ensure wider accessibility of infusion pump technologies.

This Asia-Pacific infusion pumps market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific infusion pumps market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In January 2022, ICU Medical Inc. declared that the purchase of Smiths Medical from Smiths Group plc had been completed. Syringe and ambulatory infusion devices, vascular access, and essential care products are all part of the Smiths Medical business. The combined businesses, when combined with ICU Medical's current businesses, create a market-leading infusion therapy company with pro forma combined revenues of about USD 2.5 billion

Asia-Pacific Infusion Pumps Market Scope and Market Size

The Asia-Pacific infusion pumps market is segmented on the basis of product, application, distribution channel and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Sterilization Products
  • Cleaning and Disinfection Products
  • Personal Protective Barriers
  • Endoscope Reprocessing Products
  • Anti-microbial Surfaces
  • Other Infusion Pumps Products

Application                                                                              

Distribution Channel

  • Direct Tender
  • Retail Sales
  • Third Party Distributors

End User                                 

  • Hospitals
  • Clinics
  • Medical Device Companies
  • Pharmaceutical and Biotechnology Companies
  • Laboratories
  • Others

Asia-Pacific Infusion Pumps Market Regional Analysis/Insights

The Asia-Pacific infusion pumps market is analysed and market size insights and trends are provided by country, product, application, distribution channel and end user as referenced above.

The countries covered in the Asia-Pacific infusion pumps market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the Asia-Pacific infusion pumps market due to the rise in the efforts by the established companies. Furthermore, the steady number of strategic associations adopted by key market players will further boost the growth of the Asia-Pacific infusion pumps market.

Asia-Pacific is projected to observe significant amount of growth and the fastest growing region in the Asia-Pacific infusion pumps market during the forecast period of 2023 to 2030, market due to the rise in the occurrence of outsourcing organizations. Moreover, the increasing healthcare expenses is further anticipated to propel the growth of the Infusion Pumps Market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Asia-Pacific infusion pumps market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific infusion pumps market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific infusion pumps market. The data is available for historic period 2015-2020.

Competitive Landscape and Asia-Pacific Infusion Pumps Market Share Analysis

The Asia-Pacific infusion pumps market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Asia-Pacific infusion pumps market.

 Some of the major players operating in the Asia-Pacific infusion pumps market are:

  • BD (Becton, Dickinson and Company) (U.S.)
  • B. Braun Melsungen AG (Germany)
  • Baxter (U.S.)
  • Fresenius Kabi AG (Germany)
  • ICU Medical, Inc. (U.S.)
  • Smiths Group PLC (U.K.)
  • Medtronic (U.S.)
  • Moog Inc. (U.S.)
  • Terumo Corporation (Japan)
  • Avanos Corporate (U.S.)
  • NIPRO (Japan)
  • Insulet Corporation (U.S.)
  • Tandem Diabetes Care, Inc. (U.S.)
  • JMS Co. Ltd. (Japan)
  • F. Hoffmann-La Roche Ltd. (Switzerland)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Asia-Pacific infusion pumps market size will be worth USD 6.67 billion by 2030.
The growth rate of the Asia-Pacific infusion pumps market is 4.9% in the forecast period by 2030.
The increasing prevalence of chronic diseases & technological advancement and innovation are the growth drivers of the Asia-Pacific infusion pumps market.
Product, application, distribution channel, and end user are the factors on which the Asia-Pacific infusion pumps market research is based.
Major companies in the Asia-Pacific infusion pumps market are BD (Becton, Dickinson and Company) (U.S.), B. Braun Melsungen AG (Germany), Baxter (U.S.), Fresenius Kabi AG (Germany), ICU Medical, Inc. (U.S.), Smiths Group PLC (U.K.), Medtronic (U.S.), Moog Inc. (U.S.), Terumo Corporation (Japan), Avanos Corporate (U.S.), NIPRO (Japan), Insulet Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), JMS Co. Ltd. (Japan), F. Hoffmann-La Roche Ltd. (Switzerland)
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials